Guidance for clinicians and patients with non-small cell lung cancer in the time of precision medicine

Guidance for clinicians and patients with non-small cell lung cancer in the time of precision medicine

Major advances in the diagnosis and treatment of non-small cell lung cancer (NSCLC) have resulted in a sharp decline in associated mortality rates, thereby propelling NSCLC to the forefront of precision medicine. Current guidelines recommend upfront comprehensive molecular testing for all known and...

Full description

Bibliographic Details
Main Authors: Liza C. Villaruz, Mark A. Socinski, Jared Weiss
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Oncology
Subjects:
targeted therapy
non-small cell lung cancer
biomarker testing
patient education
next-generation sequencing
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1124167/full

Similar Items

Similar Items